WiSys Technologies

14 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Information Technology" or "Engineering" or "Micro & Nanotech"

Stimuli-Responsive Smart Block Copolymers Improve Dispersion of Titanium Dioxide in Architectural Coatings

WiSys is currently seeking strategic partners in the coatings industry that are interested in co-development opportunities that would ultimately provide a route to market for commercialization of these novel copolymers.

Semiconductor Quantum Dot Computer Aided Engineering (CAE) Simulation Tool

WiSys is seeking a strategic partner skilled in the design, modeling, and fabrication of Quantum Dots and Quantum wires.  There is interest in working with a partner to test the beta version of the CAE simulation tool and provide feedback when modeling both Quantum Wires and Quantum Dots.  Additionally, there is interest in identifying a partner with a 3D finite element method solver for further development and testing of the CAE simulation tool.

Health Monitoring and Imaging System for Concrete Structures

WiSys is currently seeking strategic partners operating in the non-destructive testing industry interested in further developing this novel health monitoring system for concrete structures, ultimately providing a route to market for its commercialization.

Carbon Nanotube Vacuum Field Emission Transistor Design for Large-Scale Manufacturing

WiSys is currently seeking strategic partners in the next generation transistor industry that are interested in further optimizing the design for large-scale manufacturing, ultimately providing a path to market for its commercialization.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.